INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Corcept Therapeutics Incorporated Investors
Corcept Therapeutics Incorporated (CORT)
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corcept.com/investors
Company Research
Source: Business Wire
BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith announces an investigation on behalf of Corcept Therapeutics Incorporated investors (“Corcept” or the “Company”) (NASDAQ: CORT) concerning the Company and its officers’ possible violations of federal securities laws. On January 25, 2019, Southern Investigative Reporting Foundation (SIRF) published a report alleging that Corcept paid doctors to prescribe its drug Korlym for off-label uses in 2016 - 2017. The report condemned the company for exploiting regulatory loopholes, charging patients an excessive price for its lone drug product, and touting evidence for the drug's effectiveness that -- according to SIRF – doesn't exist." On this news, shares of Corcept fell $1.52 or 11%, to close at $12.29 on January 25, 2019, thereby injuring investors. If you purchased Corcept securities, have information or would like to learn more abou
Show less
Read more
Impact Snapshot
Event Time:
CORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CORT alerts
High impacting Corcept Therapeutics Incorporated news events
Weekly update
A roundup of the hottest topics
CORT
News
- Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Corcept Therapeutics: Key Catalysts Ahead [Seeking Alpha]Seeking Alpha
- Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow [Yahoo! Finance]Yahoo! Finance
CORT
Earnings
- 2/15/24 - Beat
CORT
Sec Filings
- 3/27/24 - Form SC
- 3/27/24 - Form 144
- 3/20/24 - Form 4
- CORT's page on the SEC website